天坛生物前三季度净利8.19亿元，同比下降22.16%

Core Viewpoint - Tian Tan Biological Products (600161) reported a revenue of 4.465 billion yuan for the first three quarters of 2025, reflecting a year-on-year growth of 9.62%, while the net profit attributable to shareholders decreased by 22.16% to 819 million yuan [1] Financial Performance - Revenue for the first three quarters reached 4.465 billion yuan, marking a 9.62% increase compared to the previous year [1] - Net profit attributable to shareholders was 819 million yuan, which represents a decline of 22.16% year-on-year [1] Factors Influencing Performance - The decrease in net profit is attributed to a decline in sales prices and an increase in credit impairment losses due to credit policy impacts [1]